Table of Contents Consolidated Cash Flows – For the six months ended June 30, 2019 and 2018: Net cash used in investing activities of $137.8 million for the six months ended June 30, 2019 consisted …

More 10-Q: EDWARDS LIFESCIENCES CORP Videos